NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,068 | -30.6% | 10,550 | -15.2% | 0.00% | -100.0% |
| Q1 2023 | $8,740 | -68.9% | 12,434 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $28,101 | -40.2% | 12,434 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $47,000 | -70.1% | 12,434 | -57.4% | 0.00% | -60.0% |
| Q1 2022 | $157,000 | -91.1% | 29,188 | -73.6% | 0.01% | -91.0% |
| Q4 2021 | $1,756,000 | +329.3% | 110,437 | +401.4% | 0.11% | +296.4% |
| Q3 2021 | $409,000 | +24.7% | 22,024 | +26.9% | 0.03% | +27.3% |
| Q2 2021 | $328,000 | +35.5% | 17,361 | +47.2% | 0.02% | +29.4% |
| Q1 2021 | $242,000 | -40.2% | 11,792 | +256.3% | 0.02% | -55.3% |
| Q2 2020 | $405,000 | -24.7% | 3,310 | -76.7% | 0.04% | -33.3% |
| Q4 2019 | $538,000 | +147.9% | 14,177 | +19.1% | 0.06% | +128.0% |
| Q3 2019 | $217,000 | – | 11,904 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |